Additional file 16 of Evaluating the national system for rare diseases in China from the point of drug access: progress and challenges
收藏数据链接：
官方服务：
资源简介：
Additional file 16: Table S16. Number of orphan drugs with better availability and affordability in each efficacy group.
创建时间：
2022-09-11
